Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
Advertisement
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Index by author

PreviousNext

April 01 1998; volume 47 issue 4

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aganna, E

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations
  2. Aguilar-Bryan, L

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  3. Almind, K

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  4. Andrikopoulos, S

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  5. Araki, E

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  6. Argyropoulos, G

    1. You have accessRestricted Access
      Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
      Add to Selected Citations
  7. Asberry, P J

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  8. Atkinson, M A

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations

B

  1. Babazono, T

    1. You have accessRestricted Access
      Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668
      Add to Selected Citations
  2. Baldoncini, R

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  3. Baskin, D G

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  4. Beger, C

    1. You have accessRestricted Access
      Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559
      Add to Selected Citations
  5. Bellini, C

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  6. Beshay, E

    1. You have accessRestricted Access
      The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
      L Liang, E Beshay and G J Prud'homme
      Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570
      Add to Selected Citations
  7. Boucher, B J

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations
  8. Boyadjian, R

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  9. Boyko, E J

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  10. Brown, A M

    1. You have accessRestricted Access
      Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
      Add to Selected Citations
  11. Brubaker, P L

    1. You have accessRestricted Access
      Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
      Add to Selected Citations
  12. Bryan, J

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  13. Bursell, S E

    1. You have accessRestricted Access
      Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653
      Add to Selected Citations

C

  1. Castillo, G M

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  2. Cherrington, A D

    1. You have accessRestricted Access
      Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
      Add to Selected Citations
  3. Chu, C A

    1. You have accessRestricted Access
      Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
      Add to Selected Citations
  4. Cirulli, V

    1. You have accessRestricted Access
      Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559
      Add to Selected Citations
  5. Clausen, J O

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  6. Clermont, A C

    1. You have accessRestricted Access
      Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653
      Add to Selected Citations
  7. Cook, S M

    1. You have accessRestricted Access
      Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
      Add to Selected Citations
  8. Corbett, J A

    1. You have accessRestricted Access
      Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
      Add to Selected Citations
  9. Cummings, J A

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations

D

  1. De Angelis, C

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  2. Desideri, G

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  3. Dhir, V

    1. You have accessRestricted Access
      Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653
      Add to Selected Citations
  4. Dittler, J

    1. You have accessRestricted Access
      GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592
      Add to Selected Citations
  5. Dlugosz, J A

    1. You have accessRestricted Access
      Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668
      Add to Selected Citations
  6. Donahue, E P

    1. You have accessRestricted Access
      Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
      Add to Selected Citations
  7. Drucker, D J

    1. You have accessRestricted Access
      Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
      Add to Selected Citations
    2. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations

E

  1. Ebina, Y

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations
  2. Echwald, S M

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  3. Eckel, J

    1. You have accessRestricted Access
      Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515
      Add to Selected Citations
  4. Ellis, T M

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  5. Erickson, J C

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  6. Eriksson, U J

    1. You have accessRestricted Access
      Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
      P Wentzel and U J Eriksson
      Diabetes 1998 Apr; 47 (4): 677-684. https://doi.org/10.2337/diabetes.47.4.677
      Add to Selected Citations

F

  1. Ferrer, J

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  2. Ferri, C

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  3. Flamez, D

    1. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations
  4. Franciosa, M D

    1. You have accessRestricted Access
      BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691
      Add to Selected Citations
  5. Fujimoto, W Y

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  6. Furukawa, N

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations

G

  1. Garvey, W T

    1. You have accessRestricted Access
      Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
      Add to Selected Citations
  2. Greenberg, A S

    1. You have accessRestricted Access
      BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691
      Add to Selected Citations

H

  1. Hagi, A

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations
  2. Halban, P A

    1. You have accessRestricted Access
      Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559
      Add to Selected Citations
  3. Hales, C N

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations
  4. Hansen, J B

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  5. Hansen, L

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  6. Hansen, T

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  7. Hauner, H

    1. You have accessRestricted Access
      Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515
      Add to Selected Citations
  8. Hauser, S

    1. You have accessRestricted Access
      Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
      Add to Selected Citations
  9. Hayashi, H

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations
  10. Higashi, S

    1. You have accessRestricted Access
      Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
      S Higashi, A C Clermont, V Dhir and S E Bursell
      Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653
      Add to Selected Citations
  11. Hill, J R

    1. You have accessRestricted Access
      Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
      Add to Selected Citations
  12. Hitman, G A

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations

I

  1. Inoue, H

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations

J

  1. Jinagouda, S D

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  2. Judge, M E

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  3. Jun, H S

    1. You have accessRestricted Access
      Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
      Add to Selected Citations

K

  1. Kahn, S E

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  2. Kamdar, V

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  3. Kaneko, K

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  4. Kang, Y

    1. You have accessRestricted Access
      Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
      Add to Selected Citations
  5. Kapor-Drezgic, J

    1. You have accessRestricted Access
      Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668
      Add to Selected Citations
  6. Khan, A

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  7. Kilpatrick, E D

    1. You have accessRestricted Access
      Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
      E D Kilpatrick and R P Robertson
      Diabetes 1998 Apr; 47 (4): 606-611. https://doi.org/10.2337/diabetes.47.4.606
      Add to Selected Citations
  8. Kim, K H

    1. You have accessRestricted Access
      Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
      Add to Selected Citations
  9. Kishi, K

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations
  10. Kishikawa, H

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  11. Kuijper, J L

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  12. Kwon, G

    1. You have accessRestricted Access
      Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
      Add to Selected Citations

L

  1. Lan, M S

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  2. Larsen, P J

    1. You have accessRestricted Access
      Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
      M Tang-Christensen, N Vrang and P J Larsen
      Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530
      Add to Selected Citations
  3. Leonetti, D L

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  4. Liang, L

    1. You have accessRestricted Access
      The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
      L Liang, E Beshay and G J Prud'homme
      Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570
      Add to Selected Citations
  5. Lien, P

    1. You have accessRestricted Access
      BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691
      Add to Selected Citations
  6. Likes, C E

    1. You have accessRestricted Access
      Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
      Add to Selected Citations
  7. Liu, L S

    1. You have accessRestricted Access
      Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515
      Add to Selected Citations
  8. Lok, S

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations

M

  1. Maclaren, N K

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  2. Mannan, N

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations
  3. Marshall, B A

    1. You have accessRestricted Access
      Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
      Add to Selected Citations
  4. Matsumoto, K

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  5. Mazzocchi, C

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  6. McDaniel, M L

    1. You have accessRestricted Access
      Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
      Add to Selected Citations
  7. McDermott, M F

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations
  8. Menger, M D

    1. You have accessRestricted Access
      Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559
      Add to Selected Citations
  9. Michael, R

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  10. Miyata, I

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations
  11. Miyazaki, J

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  12. Møller, A M

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  13. Motoshima, H

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  14. Muromoto, N

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations

N

  1. Nakaya, Y

    1. You have accessRestricted Access
      Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
      K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina
      Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550
      Add to Selected Citations
  2. Neal, D W

    1. You have accessRestricted Access
      Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
      Add to Selected Citations
  3. Newell-Morris, L

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  4. Notkins, A L

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
    2. You have accessRestricted Access
      Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
      Add to Selected Citations

O

  1. Ogunkolade, B W

    1. You have accessRestricted Access
      Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
      G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher
      Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688
      Add to Selected Citations
  2. Ottendorfer, E W

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations

P

  1. Palmiter, R D

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  2. Pedersen, O

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  3. Permutt, M A

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations
  4. Peterson, R

    1. You have accessRestricted Access
      Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
      Add to Selected Citations
  5. Pipeleers, D

    1. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations
  6. Prud'homme, G J

    1. You have accessRestricted Access
      The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
      L Liang, E Beshay and G J Prud'homme
      Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570
      Add to Selected Citations

Q

  1. Quartier, E

    1. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations

R

  1. Riad-Gabriel, M G

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  2. Rimvall, K

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  3. Robertson, R P

    1. You have accessRestricted Access
      Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
      E D Kilpatrick and R P Robertson
      Diabetes 1998 Apr; 47 (4): 606-611. https://doi.org/10.2337/diabetes.47.4.606
      Add to Selected Citations
  4. Röhrig, K

    1. You have accessRestricted Access
      Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515
      Add to Selected Citations

S

  1. Saad, M F

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  2. Salisbury, P J

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  3. Santucci, A

    1. You have accessRestricted Access
      Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
      C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci
      Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660
      Add to Selected Citations
  4. Schatz, D A

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  5. Schenker, M

    1. You have accessRestricted Access
      GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592
      Add to Selected Citations
  6. Schuit, F

    1. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations
  7. Schwartz, M W

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  8. Schwartz, R S

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  9. Scrocchi, L A

    1. You have accessRestricted Access
      Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
      L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker
      Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632
      Add to Selected Citations
    2. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations
  10. Seeley, R J

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  11. Seidel, D

    1. You have accessRestricted Access
      GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592
      Add to Selected Citations
  12. Sharma, A

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations
  13. She, J X

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  14. Sheardown, M J

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  15. Shichiri, M

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  16. Shirakami, A

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  17. Shirotani, T

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  18. Sindelar, D K

    1. You have accessRestricted Access
      Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
      Add to Selected Citations
  19. Snow, A D

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  20. Souza, S C

    1. You have accessRestricted Access
      BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691
      Add to Selected Citations
  21. Spelleken, M

    1. You have accessRestricted Access
      Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
      L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel
      Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515
      Add to Selected Citations
  22. Spiegelman, B M

    1. You have accessRestricted Access
      PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
      B M Spiegelman
      Diabetes 1998 Apr; 47 (4): 507-514. https://doi.org/10.2337/diabetes.47.4.507
      Add to Selected Citations
  23. Steil, G M

    1. You have accessRestricted Access
      Physiological insulinemia acutely modulates plasma leptin.
      M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar
      Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544
      Add to Selected Citations

T

  1. Tang-Christensen, M

    1. You have accessRestricted Access
      Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
      M Tang-Christensen, N Vrang and P J Larsen
      Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530
      Add to Selected Citations
  2. Tsuruzoe, K

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations
  3. Turk, J

    1. You have accessRestricted Access
      Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
      G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel
      Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583
      Add to Selected Citations

U

  1. Urhammer, S A

    1. You have accessRestricted Access
      Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
      T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen
      Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598
      Add to Selected Citations

V

  1. Vajkoczy, P

    1. You have accessRestricted Access
      Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
      C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger
      Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559
      Add to Selected Citations
  2. Van Breusegem, A

    1. You have accessRestricted Access
      Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
      D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit
      Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646
      Add to Selected Citations
  3. Venson, P

    1. You have accessRestricted Access
      Basal hepatic glucose production is regulated by the portal vein insulin concentration.
      D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington
      Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523
      Add to Selected Citations
  4. Verchere, C B

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  5. Vrang, N

    1. You have accessRestricted Access
      Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
      M Tang-Christensen, N Vrang and P J Larsen
      Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530
      Add to Selected Citations

W

  1. Wahl, P W

    1. You have accessRestricted Access
      Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
      S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto
      Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640
      Add to Selected Citations
  2. Wasserfall, C

    1. You have accessRestricted Access
      The relationship between humoral and cellular immunity to IA-2 in IDDM.
      T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson
      Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566
      Add to Selected Citations
  3. Watson, D K

    1. You have accessRestricted Access
      Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
      G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey
      Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685
      Add to Selected Citations
  4. Weigle, D S

    1. You have accessRestricted Access
      Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
      D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz
      Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538
      Add to Selected Citations
  5. Wentzel, P

    1. You have accessRestricted Access
      Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
      P Wentzel and U J Eriksson
      Diabetes 1998 Apr; 47 (4): 677-684. https://doi.org/10.2337/diabetes.47.4.677
      Add to Selected Citations
  6. Whiteside, C

    1. You have accessRestricted Access
      Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
      T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside
      Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668
      Add to Selected Citations

Y

  1. Yamamoto, M T

    1. You have accessRestricted Access
      BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
      S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg
      Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691
      Add to Selected Citations
  2. Yang, W

    1. You have accessRestricted Access
      Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
      G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow
      Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612
      Add to Selected Citations
  3. Yoon, H S

    1. You have accessRestricted Access
      Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
      Add to Selected Citations
  4. Yoon, J W

    1. You have accessRestricted Access
      Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
      H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon
      Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576
      Add to Selected Citations
  5. Yoshizato, K

    1. You have accessRestricted Access
      Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
      K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri
      Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621
      Add to Selected Citations

Z

  1. Ziegler, A G

    1. You have accessRestricted Access
      GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
      J Dittler, D Seidel, M Schenker and A G Ziegler
      Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592
      Add to Selected Citations
Back to top
PreviousNext
Advertisement

In this Issue

April 1998, 47(4)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Advertisement
  • Most Read
  • Most Cited
Loading
  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
  • Latent Autoimmune Diabetes in Adults
  • Poverty and Obesity in the U.S.
  • Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes
  • From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
More...

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • For Advertisers
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Scientific Sessions Abstracts
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org
Advertisement

© 2019 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.